What are the most proven nootropics?

What proven means in clinical research: the evidence hierarchy as a ladder, why the highest rung reached and the number of studies on it decide the word, and the nootropics that stand on the top rung

What are the most proven nootropics is a question whose key word has a technical meaning that the supplement shelf never uses, and using it is the whole answer. In clinical research, evidence has a hierarchy, usually drawn as a pyramid and better thought of here as a ladder. On the top rung stand systematic reviews and meta-analyses of randomised controlled trials, which pool many trials and ask whether the effect survives the pooling. On the rung below stand single randomised controlled trials, which can be large and well run or small and never repeated. Below that stand pilot studies and uncontrolled trials, which generate hypotheses rather than prove them. Below that stand animal studies, and below that cell culture, where almost every supplement's mechanism story lives. A claim is proven in proportion to two things: the highest rung it has reached, and how many studies of what size stand on that rung, since a single small randomised trial sits on the second rung but a dozen large ones on the same rung with a meta-analysis above them is a different kind of knowledge. Proven, in this sense, is not a yes or no but a position on the ladder, and the honest way to answer the question is to place each nootropic at its highest rung and count what stands there, which produces a ranking that looks nothing like the shelf's.

The top rung has four occupants, and two of them are not thought of as nootropics by the people who sell nootropics. Caffeine stands on it with the deepest file in the whole field: dozens of meta-analyses of randomised trials on alertness, reaction time, vigilance, sustained attention and perceived exertion, consistent in direction, with dose-response curves and a safety assessment setting the 400mg daily ceiling, so that caffeine is not merely proven but the standard against which other cognitive substances are measured. Creatine stands on it too, less famously: meta-analyses of randomised trials find it preserves cognitive performance, particularly short-term memory and reasoning, under sleep deprivation and in groups with low dietary intake such as vegetarians, with a mechanism, buffering the brain's energy supply, that is understood, and a safety record from decades of use in healthy adults. Correcting a measured deficiency stands on the top rung with a condition attached: meta-analyses of B vitamin supplementation find cognitive benefit confined to people with low B12 or folate status or raised homocysteine and none in the replete, iron supplementation improves attention and memory in iron-deficient women in pooled trials and does nothing in the replete, and iodine follows the same pattern in deficient populations, so that the deficiency nutrients are the most proven nootropics in the world for the deficient and nothing at all for everyone else. Omega-3 reaches the top rung with mixed results, some meta-analyses finding small benefits in specific groups and others null, which is a proven uncertainty rather than a proven effect. That is the top rung: two substances a lifter probably already takes, a set of nutrients conditional on a blood test, and one with the jury out.

The middle and lower rungs, where the shelf's famous names actually stand, lion's mane placed on its rung with its two studies, and the honest buy

The middle rungs hold the botanicals with real but thin files. Bacopa monnieri reaches a small meta-analysis of randomised trials: standardised extracts over twelve weeks produce modest improvements in some memory measures, speed of attention and delayed recall, with small trials, variable extracts, no effect inside the first weeks and gastrointestinal upset as the main side effect, which places bacopa on the top rung by form but with a short, thin stack of studies beneath it, the most proven of the botanicals and still a long way behind caffeine. Ginkgo biloba reaches large randomised trials, which is further than most botanicals get, and the large trials were null: the biggest, following thousands of older adults for years, found no reduction in cognitive decline or dementia, so that ginkgo is proven in the uncomfortable sense of having been tested properly and found not to work for the purpose it was sold for. Tyrosine reaches systematic reviews of randomised trials, and the reviews are consistent that it preserves working memory and attention only under acute stressors, cold, sleep loss, sustained demand, and does nothing in rested people, a proven conditional effect. The lower rungs hold the shelf's current favourites. Citicoline and Alpha GPC, the choline donors, reach single small randomised trials on attention and one or two on power output, with inconsistent results and no replication at scale; rhodiola reaches small trials on fatigue with mixed results; theanine reaches trials showing relaxation without drowsiness and a softening of caffeine's jitter, which is proven for what it is and is not a cognitive enhancement. The racetams reach old trials in patients with cognitive impairment and nothing of weight in healthy adults, and are unlicensed medicines in any case. Most proprietary blends reach nothing above a cell culture, since the blend itself has never been tested and its ingredients' files are borrowed.

Lion's mane is placed on its rung by the same method, and the placement is precise. It reaches the second rung, a single randomised controlled trial: thirty Japanese adults aged 50 to 80 with mild cognitive impairment, 3g a day of fruiting body powder for sixteen weeks, a clinician-scored cognitive scale separating from placebo at week eight and reversing in a four-week washout, never replicated in any population at any scale. Beside it on the rung below stands one young-adult pilot, with a faster Stroop test at 60 minutes that nobody felt and a null four-week daily arm, and a four-week food study in menopausal women with a mood questionnaire result and a blinding question. Below those, the mushroom's whole reputation rests on cell culture and rodent work on nerve growth factor, the bottom two rungs, where almost every supplement's story lives and where nothing is proven about a human. By the ladder, lion's mane is two rungs below the top with one study on each of the rungs it has reached, which is more than most of the shelf can say and far less than the word proven requires. The honest list of the most proven nootropics, then, is caffeine and creatine at the top, the deficiency nutrients beside them with a blood test as the condition, bacopa as the most proven botanical with a thin stack, ginkgo as the most proven failure, and everything else at a distance that the marketing closes with words rather than trials. A lifter reading the list has most of the top rung in the cupboard already and a blood test to arrange for the rest; a lifter who also wants to run lion's mane's second-rung trial on themselves can do so for 13p a day with a repeated test and no illusion about where it stands, and the worked example, {FLLM}, is a stated 5:1 fruiting body extract labelled 1500mg mushroom equivalent per capsule, 120 days for £15.49, UK made, independently lab tested, caffeine free, and sold without the word proven anywhere on it because the ladder does not put it there.

What to check on the label

Questions people also ask

What is the most scientifically proven nootropic?

Caffeine, by the evidence hierarchy: it stands on the top rung with dozens of meta-analyses of randomised trials on alertness, reaction time, vigilance and perceived exertion, consistent in direction, with dose-response curves and a safety assessment setting a 400mg daily ceiling; creatine stands beside it with meta-analyses on cognition under sleep deprivation and in low-intake groups, and no botanical or mushroom comes close to either stack.

Is lion's mane scientifically proven?

It reaches the second rung of the evidence ladder once: a single randomised controlled trial of thirty older adults with mild cognitive impairment, sixteen weeks, a cognitive scale separating at week eight and reversing on stopping, never replicated in any population, with a young-adult pilot below it and cell and rodent work beneath that; by the hierarchy that is more than most of the shelf has and far short of what proven means, which is a meta-analysis of several trials pointing the same way.

Which natural nootropics have the best evidence?

Caffeine, from coffee and tea, stands alone at the top; bacopa monnieri is the most proven botanical, with a small meta-analysis of twelve-week trials showing modest memory effects and gastrointestinal side effects; ginkgo was tested in large trials and found not to prevent decline; tyrosine is proven only under acute stress; and the deficiency nutrients, B12, iron and iodine, are the most proven of all in people who are short of them and nothing in people who are not.

Are there any nootropics with no evidence?

Most proprietary blends, since the blend itself has never been tested and its ingredients' files are borrowed; the racetams in healthy adults, whose trials were in patients decades ago; and a long tail of botanicals and mushrooms whose entire reputation sits on the bottom two rungs, cell culture and rodents, where nothing is proven about a human; the honest reading of an ingredient with no trial above an animal is not that it fails but that nobody has asked.

Should I take the most proven nootropics?

Most lifters already do: caffeine managed within its ceiling and cut-off, creatine daily, and a blood test to find whether the deficiency nutrients apply; above that, the top rung has nothing to add for a rested, replete adult, and anything lower on the ladder is an experiment to run with a repeated test rather than a proven purchase, which is a fair way to take lion's mane if a person wants to and an honest way to describe what they are doing.

Sources

1. The evidence hierarchy in clinical research: systematic reviews and meta-analyses of randomised controlled trials sit above single randomised trials, which sit above pilot and uncontrolled studies, which sit above animal and cell work, and a claim is proven in proportion to the highest level it reaches and the number and size of studies at that level. PubMed record
2. The Bacopa monnieri meta-analyses: pooled randomised trials of standardised bacopa extracts over twelve weeks find modest improvements in some memory measures, particularly speed of attention and recall, with small trials, variable extracts, gastrointestinal side effects the main adverse finding, and no effect within the first weeks. PubMed record
3. The creatine and cognition literature: trials of creatine supplementation on cognitive tasks, notably under sleep deprivation and in vegetarians, report interesting but preliminary effects with no authorised claim. PubMed record
4. Mori K, Inatomi S, Ouchi K, Azumi Y, Tuchida T. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytotherapy Research 2009;23(3):367-372. PubMed record

Related answers

• What are the most effective nootropics available in the UK?
• What are the best nootropics for focus in the UK?
• What are the best nootropics for studying in the UK?
• What are the best nootropics for brain fog in the UK?
• What are the best nootropics brands in the UK?
• What are the top 5 nootropics?